The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma

Anticancer Research

Volumn 34, Issue 12, 2014, Pages 7137-7143

  Lu, Cheng Tung ^a   Hsu, Cheng Ming ^a   Lin, Pai Mei ^b   Lai, Chi Chih ^a   Lin, Hsin Ching ^a   Yang, Chao Hui ^a   Hsiao, Hui Hua ^c,d   Liu, Yi Chang ^c,d   Lin, Hugo You Hsien ^c,e   Lin, Sheng Fung ^c,d   Yang, Ming Yu ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

HNSCC; Peripheral blood leukocytes; SIRT6; SIRT7; Sirtuin genes

Indexed keywords

BIOLOGICAL MARKER; SIRTUIN 6; SIRTUIN 7; TUMOR MARKER; SIRT1 PROTEIN, HUMAN; SIRT3 PROTEIN, HUMAN; SIRT6 PROTEIN, HUMAN; SIRT7 PROTEIN, HUMAN; SIRTUIN; SIRTUIN 1; SIRTUIN 3;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC MARKER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MULTIGENE FAMILY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK NEOPLASMS; MIDDLE AGED;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; SIRTUIN 1; SIRTUIN 3; SIRTUINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84918559371     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Department of Health ET, R.O.C.: Cancer registry annual report in Taiwan area, 2010. 2013
2. Pinto FR, Matos LL, Gumz Segundo W, Vanni CM, Rosa DS and Kanda JL: Tobacco and alcohol use after head and neck cancer treatment: influence of the type of oncological treatment employed. Rev Assoc Med Bras 57(2): 171-176, 2011.
3. Hashibe M, Hunt J, Wei M, Buys S, Gren L and Lee YC: Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck 35(7): 914-922, 2013.
4. Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, Lu YC, Li HF and Cheng AJ: Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 99(8): 1507-1514, 2008.
5. Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ and Jeng JH: Cell-mediated immunity and head and neck cancer: with special empha-sis on betel quid chewing habit. Oral Oncol 41(8): 757-775, 2005.
6. Smith EM, Rubenstein LM, Haugen TH, Pawlita M and Turek LP: Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol 2012: 571862, 2012.
7. Mao L, Hong WK and Papadimitrakopoulou VA: Focus on head and neck cancer. Cancer Cell 5(4): 311-316, 2004.
8. Imai SI and Guarente L: NAD+ and sirtuins in aging and disease. Trends Cell Biol 24(8): 464-471, 2014.
9. Hallows WC, Albaugh BN and Denu JM: Where in the cell is SIRT3?-functional localization of an NAD+-dependent protein deacetylase. Biochem J 411(2): e11-13, 2008.
10. Lafontaine-Lacasse M, Richard D and Picard F: Effects of age and gender on Sirt 1 mRNA expressions in the hypothalamus of the mouse. Neurosci Lett 480(1): 1-3, 2010.
11. Suwa M and Sakuma K: The potential role of sirtuins regarding the effects of exercise on aging- related diseases. Curr Aging Sci 6(2): 178-188, 2013.
12. Pulla VK, Battu MB, Alvala M, Sriram D and Yogeeswari P: Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review. Expert Opin Ther Targets 16(8): 819-832, 2012.
13. Donato AJ, Magerko KA, Lawson BR, Durrant JR, Lesniewski LA and Seals DR: SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 589: 4545-554, 2011.
14. Suzuki K and Koike T: Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience 147(3): 599-612, 2007.
15. Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW and Schibler U: SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134(2): 317-328, 2008.
16. Bosch-Presegue L and Vaquero A: The dual role of sirtuins in cancer. Genes Cancer 2(6): 648-662, 2011.
17. Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML, Hsu CM and Yang MY: Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol 34(3): 1847-1854, 2013.
18. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144(5): 646-674, 2011.
19. Roth M and Chen WY: Sorting out functions of sirtuins in cancer. Oncogene 33(13): 1609-1620, 2014.
20. Lee KD, Lee HS and Jeon CH: Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. Anticancer Res 31(4): 1161-1167, 2011.
21. Park NJ, Zhou X, Yu T, Brinkman BM, Zimmermann BG, Palanisamy V and Wong DT: Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol 52(1): 30-35, 2007.
22. Zimmermann BG, Park NJ and Wong DT: Genomic targets in saliva. Ann NY Acad Sci 1098: 184-191, 2007.
23. Kuropkat C, Plehn S, Herz U, Dunne AA, Renz H and Werner JA: Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. Anticancer Res 22(4): 2221-2227, 2002.
24. Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, Arciero C, Russell S, Garguilo G, Hooke J and Somiari RI: Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett 233(1): 98-107, 2006.
25. Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, Chuang LY, Wen CH and Chang HW: Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 14(4): 244-249, 2009.
26. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E and Wong DT: Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(8): 929-935, 2004.
27. Faria PC, Sena AA, Nascimento R, Carvalho WJ, Loyola AM, Silva SJ, Durighetto AF, Oliveira AD, Oliani SM and Goulart LR: Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. Oral Oncol 46(1): 25-30, 2010.
28. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF and Yang MY: Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 33(6): 1933-1942, 2012.
29. Hsu CM, Lin PM, Lai CC, Lin HC, Lin SF and Yang MY: PER1 and CLOCK are potential circulating biomarkers for head and neck squamous cell carcinoma. Head Neck 36(7): 1018-1026, 2014.
30. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, Guimaraes A, Marinelli B, Wikstrom JD, Nir T, Clish CB, Vaitheesvaran B, Iliopoulos O, Kurland I, Dor Y, Weissleder R, Shirihai OS, Ellisen LW, Espinosa JM and Mostoslavsky R: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140(2): 280-293, 2010.
31. Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, Cosentino C, Greenson JK, MacDonald AI, McGlynn L, Maxwell F, Edwards J, Giacosa S, Guccione E, Weissleder R, Bernstein BE, Regev A, Shiels PG, Lombard DB and Mostoslavsky R: The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151(6): 1185-1199, 2012.
32. Van Meter M, Mao Z, Gorbunova V and Seluanov A: SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle 10(18): 3153-3158, 2011.
33. Barber MF(1), Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, Struhl K, Garcia BA, Gozani O, Li W and Chua KF: SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487(7405): 114-118, 2012.